Evolution of diabetes insulin delivery devices.
The first manufactured insulin pump was introduced in the 1970s and the first insulin pens in 1985; since then, many improvements have been made to both devices. The advantages of pens over syringes have been confirmed in numerous studies and include greater accuracy, ease of use, patient satisfaction, quality of life, and adherence. United States claims database analyses indicate that the improved adherence made possible by use of an insulin pen has the potential to reduce diabetes care costs when compared with using a vial and syringe. Features of certain advanced pump models include the ability to connect wirelessly to a blood glucose meter or to a subcutaneous interstitial glucose sensor for semicontinuous glucose-driven insulin rate adjustment. A new trend in the design of insulin pumps is the tubing-free patch pump that adheres directly to the skin. The low rate of insulin pen usage in the United States compared with European countries and the fact that many patients report that they are not offered the option of an insulin pen by their physician suggest that there is a need to increase patient and provider awareness of the currently available devices for insulin administration.
Selam
Jean-Louis
JL
Diabetes Research Center, Tustin, California 92780, USA. jlselam@cox.net
D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000191:economics; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000191:economics; D007328:Insulin / Q000008:administration & dosage* / Q000191:economics; D007332:Insulin Infusion Systems / Q000009:adverse effects / Q000191:economics / Q000706:statistics & numerical data; D055118:Medication Adherence; D057240:Patient Preference; D012646:Self Administration / Q000191:economics / Q000295:instrumentation / Q000379:methods; D013594:Syringes / Q000191:economics
D007004:Hypoglycemic Agents; D007328:Insulin